AI Medical Compendium Journal:
Trends in pharmacological sciences

Showing 11 to 20 of 23 articles

Disrupting 3D printing of medicines with machine learning.

Trends in pharmacological sciences
3D printing (3DP) is a progressive technology capable of transforming pharmaceutical development. However, despite its promising advantages, its transition into clinical settings remains slow. To make the vital leap to mainstream clinical practice an...

Machine Learning for Biologics: Opportunities for Protein Engineering, Developability, and Formulation.

Trends in pharmacological sciences
Successful biologics must satisfy multiple properties including activity and particular physicochemical features that are globally defined as developability. These multiple properties must be simultaneously optimized in a very broad design space of p...

Single-Cell Techniques and Deep Learning in Predicting Drug Response.

Trends in pharmacological sciences
Rapidly developing single-cell sequencing analyses produce more comprehensive profiles of the genomic, transcriptomic, and epigenomic heterogeneity of tumor subpopulations than do traditional bulk sequencing analyses. Moreover, single-cell techniques...

Has Drug Design Augmented by Artificial Intelligence Become a Reality?

Trends in pharmacological sciences
The application of artificial intelligence (AI) to drug discovery has become a hot topic in recent years. Generative molecular design based on deep learning is a particular an area of attention. Zhavoronkov et al. recently published a novel approach ...

Artificial Intelligence for Drug Toxicity and Safety.

Trends in pharmacological sciences
Interventional pharmacology is one of medicine's most potent weapons against disease. These drugs, however, can result in damaging side effects and must be closely monitored. Pharmacovigilance is the field of science that monitors, detects, and preve...

Artificial Intelligence for Clinical Trial Design.

Trends in pharmacological sciences
Clinical trials consume the latter half of the 10 to 15 year, 1.5-2.0 billion USD, development cycle for bringing a single new drug to market. Hence, a failed trial sinks not only the investment into the trial itself but also the preclinical developm...

Advancing Drug Discovery via Artificial Intelligence.

Trends in pharmacological sciences
Drug discovery and development are among the most important translational science activities that contribute to human health and wellbeing. However, the development of a new drug is a very complex, expensive, and long process which typically costs 2....

Deep Aging Clocks: The Emergence of AI-Based Biomarkers of Aging and Longevity.

Trends in pharmacological sciences
First published in 2016, predictors of chronological and biological age developed using deep learning (DL) are rapidly gaining popularity in the aging research community. These deep aging clocks can be used in a broad range of applications in the pha...

Artificial Intelligence: A Novel Approach for Drug Discovery.

Trends in pharmacological sciences
Molecular dynamics (MD) simulations can mechanistically explain receptor function. However, the enormous data sets that they may imply can be a hurdle. Plante and colleagues (Molecules, 2019) recently described a machine learning approach to the anal...